Results 161 to 170 of about 51,116 (225)

The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient. [PDF]

Eur J Heart Fail
Kinoshita H, Sugino H, Kodama M, Saito M, Sumimoto Y, Masada K, Shimonaga T, Suga A, Toko M, Taniyasu K, Ushirozako S, Katayama Y, Hirahara C, Takada M.   +13 more
europepmc   +1 more source

Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction. [PDF]

PLoS One
Bergo KK, Nordén ES, Bendiksen BA, Espe EKS, McGinley G, Hauge-Iversen IM, Hussain RI, Leh S, Marti HP, Zhang L, Sjaastad I, Cataliotti A.   +11 more
europepmc   +1 more source

Degradation of Toxins and Metabolites of Cyanobacteria and Micropollutants during Biological Sand Filtration. [PDF]

Environ Sci Technol
Rougé V, Dax A, Köster O, von Gunten U, Janssen EM.   +4 more
europepmc   +1 more source

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

JACC Adv
Kido K, Hashiguchi M, Guglin M.
europepmc   +1 more source

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Wang S, Lai J, Chen J, Luo Q, Yi W, Lai Y.   +5 more
europepmc   +1 more source

Evaluation of potential of <i>Revstone</i> ^® on gentamicin-induced renal toxicity in Wistar rats: a comparative study of the capsule and syrup forms. [PDF]

Front Pharmacol
Dawane JS, Dhande P, Shukla CD, Dhakne A.   +3 more
europepmc   +1 more source

Therapeutic potential of valsartan in overcoming chemoresistance in human glioblastoma. [PDF]

Sci Prog
Hu JR, Kao Y, Chang YL, Yang FC, Tsai CK, Hueng DY.   +5 more
europepmc   +1 more source

Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials. [PDF]

BMC Cardiovasc Disord
Wu J, Di H, Zhang Y, Zeng X.
europepmc   +1 more source

Valsartan Mitigates LPS-Induced Neuroinflammation and Cognitive Deficits via Modulation of RAS-ECS Crosstalk in Mice. [PDF]

Mol Neurobiol
Salama A, Elgohary R, Elesawy WH.
europepmc   +1 more source